Therapeutic Role of Probiotics Against Environmental-Induced Hepatotoxicity: Mechanisms, Clinical Perspectives, Limitations, and Future
- PMID: 39316257
- DOI: 10.1007/s12602-024-10365-6
Therapeutic Role of Probiotics Against Environmental-Induced Hepatotoxicity: Mechanisms, Clinical Perspectives, Limitations, and Future
Abstract
Hepatotoxicity is one of the biggest health challenges, particularly in the context of liver diseases, often aggravated by gut microbiota dysbiosis. The gut-liver axis has been regarded as a key idea in liver health. It indicates that changes in gut flora caused by various hepatotoxicants, including alcoholism, acetaminophen, carbon tetrachloride, and thioacetamide, can affect the balance of the gut's microflora, which may lead to increased dysbiosis and intestinal permeability. As a result, bacterial endotoxins would eventually enter the bloodstream and liver, causing hepatotoxicity and inducing inflammatory reactions. Many treatments, including liver transplantation and modern drugs, can be used to address these issues. However, because of the many side effects of these approaches, scientists and medical experts are still hoping for a therapeutic approach with fewer side effects and more positive results. Thus, probiotics have become well-known as an adjunctive strategy for managing, preventing, or reducing hepatotoxicity in treating liver injury. By altering the gut microbiota, probiotics offer a secure, non-invasive, and economical way to improve liver health in the treatment of hepatotoxicity. Through various mechanisms such as regulation of gut microbiota, reduction of pathogenic overgrowth, suppression of inflammatory mediators, modification of hepatic lipid metabolism, improvement in the performance of the epithelial barrier of the gut, antioxidative effects, and modulation of mucosal immunity, probiotics play their role in the treatment and prevention of hepatotoxicity. This review highlights the mechanistic effects of probiotics in environmental toxicants-induced hepatotoxicity and current findings on this therapeutic approach's experimental and clinical trials.
Keywords: Alcoholic liver diseases; Hepatotoxicants; Non-alcoholic fatty liver disease; Probiotics.
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Declarations. Ethics Approval: No animal was used in current study, so ethical statement is not applicable. Consent to Participate: Not applicable. Consent for Publication: Not applicable. Competing Interests: The authors declare no competing interests.
Similar articles
-
Contribution of gut microbiota to drug-induced liver injury.Hepatobiliary Pancreat Dis Int. 2023 Oct;22(5):458-465. doi: 10.1016/j.hbpd.2023.06.008. Epub 2023 Jun 13. Hepatobiliary Pancreat Dis Int. 2023. PMID: 37365109 Review.
-
Gut microbiota and host metabolism in liver cirrhosis.World J Gastroenterol. 2015 Nov 7;21(41):11597-608. doi: 10.3748/wjg.v21.i41.11597. World J Gastroenterol. 2015. PMID: 26556989 Free PMC article. Review.
-
Understanding the Effects of Gut Microbiota Dysbiosis on Nonalcoholic Fatty Liver Disease and the Possible Probiotics Role: Recent Updates.Int J Biol Sci. 2021 Feb 8;17(3):818-833. doi: 10.7150/ijbs.56214. eCollection 2021. Int J Biol Sci. 2021. PMID: 33767591 Free PMC article. Review.
-
Gut-liver axis and probiotics: their role in non-alcoholic fatty liver disease.World J Gastroenterol. 2014 Nov 14;20(42):15518-31. doi: 10.3748/wjg.v20.i42.15518. World J Gastroenterol. 2014. PMID: 25400436 Free PMC article. Review.
-
Role of Probiotics in Non-alcoholic Fatty Liver Disease: Does Gut Microbiota Matter?Nutrients. 2019 Nov 19;11(11):2837. doi: 10.3390/nu11112837. Nutrients. 2019. PMID: 31752378 Free PMC article. Review.
Cited by
-
The Potential Role and Effective Components of Sanyeqing as the Potential Therapeutic Candidates for IBD and CRC.Onco Targets Ther. 2025 Jul 7;18:779-788. doi: 10.2147/OTT.S516341. eCollection 2025. Onco Targets Ther. 2025. PMID: 40655939 Free PMC article. Review.
References
-
- Rusyn I, Arzuaga X, Cattley RC, Corton JC, Ferguson SS, Godoy P, Guyton KZ, Kaplowitz N, Khetani SR, Roberts RA (2021) Key characteristics of human hepatotoxicants as a basis for identification and characterization of the causes of liver toxicity. Hepatology 74(6):3486–3496 - PubMed
-
- Zhang Y, Qi Y, Huang S, Jiang X, Xiao W, Wang L, Liu Z, Liu S (2022) Role of ER stress in xenobiotic-induced liver diseases and hepatotoxicity. Oxidative Med Cell Longev 2022. https://doi.org/10.1155/2022/4640161
-
- Almatroodi SA, Anwar S, Almatroudi A, Khan AA, Alrumaihi F, Alsahli MA, Rahmani AH (2020) Hepatoprotective effects of garlic extract against carbon tetrachloride (CCl4)-induced liver injury via modulation of antioxidant, anti-inflammatory activities and hepatocyte architecture. Appl Sci 10(18):6200
-
- Paik JM, Golabi P, Younossi Y, Mishra A, Younossi ZM (2020) Changes in the global burden of chronic liver diseases from 2012 to 2017: the growing impact of NAFLD. Hepatology 72(5):1605–1616 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials